Harmony Biosciences Holdings (HRMY) Return on Sales: 2020-2025
Historic Return on Sales for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to 0.19%.
- Harmony Biosciences Holdings' Return on Sales rose 3.00% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 3.00%. This contributed to the annual value of 0.16% for FY2024, which is 3.00% down from last year.
- Per Harmony Biosciences Holdings' latest filing, its Return on Sales stood at 0.19% for Q3 2025, which was down 3.55% from 0.20% recorded in Q2 2025.
- Over the past 5 years, Harmony Biosciences Holdings' Return on Sales peaked at 0.41% during Q4 2022, and registered a low of 0.05% during Q1 2021.
- In the last 3 years, Harmony Biosciences Holdings' Return on Sales had a median value of 0.20% in 2025 and averaged 0.23%.
- Per our database at Business Quant, Harmony Biosciences Holdings' Return on Sales spiked by 34bps in 2021 and then declined by 25bps in 2024.
- Harmony Biosciences Holdings' Return on Sales (Quarterly) stood at 0.11% in 2021, then spiked by 31bps to 0.41% in 2022, then declined by 22bps to 0.20% in 2023, then fell by 3bps to 0.16% in 2024, then rose by 3bps to 0.19% in 2025.
- Its Return on Sales stands at 0.19% for Q3 2025, versus 0.20% for Q2 2025 and 0.17% for Q1 2025.